TG Therapeutics (TGTX) posted a net profit margin of 13.3%, down from 27.6% a year ago, but remained profitable with strong momentum. Five-year average annual earnings growth reached 48.3%. The ...

TG Therapeutics Inc (TGTX) reports a 93% revenue increase, driven by BRIUMVI sales, while navigating competitive challenges ...

Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the TD Cowen Immunology & Inflammation Summit, which is taking place virtually from November 12 – 13, 2025. The fireside ...

Detailed price information for Sweetgreen Inc Cl A (SG-N) from The Globe and Mail including charting and trades.

As it has been explained to me, reaching for your phone immediately after waking up is most likely bad for you. I often do it ...